chr19-3110351-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002067.5(GNA11):​c.321+18T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.449 in 1,592,064 control chromosomes in the GnomAD database, including 164,435 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.38 ( 11806 hom., cov: 32)
Exomes 𝑓: 0.46 ( 152629 hom. )

Consequence

GNA11
NM_002067.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -3.24

Publications

10 publications found
Variant links:
Genes affected
GNA11 (HGNC:4379): (G protein subunit alpha 11) The protein encoded by this gene belongs to the family of guanine nucleotide-binding proteins (G proteins), which function as modulators or transducers in various transmembrane signaling systems. G proteins are composed of 3 units: alpha, beta and gamma. This gene encodes one of the alpha subunits (subunit alpha-11). Mutations in this gene have been associated with hypocalciuric hypercalcemia type II (HHC2) and hypocalcemia dominant 2 (HYPOC2). Patients with HHC2 and HYPOC2 exhibit decreased or increased sensitivity, respectively, to changes in extracellular calcium concentrations. [provided by RefSeq, Dec 2013]
GNA11 Gene-Disease associations (from GenCC):
  • autosomal dominant hypocalcemia 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • congenital hemangioma
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • familial hypocalciuric hypercalcemia 2
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet
  • autosomal dominant hypocalcemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 19-3110351-T-G is Benign according to our data. Variant chr19-3110351-T-G is described in ClinVar as Benign. ClinVar VariationId is 258546.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.467 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GNA11NM_002067.5 linkc.321+18T>G intron_variant Intron 2 of 6 ENST00000078429.9 NP_002058.2 P29992

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GNA11ENST00000078429.9 linkc.321+18T>G intron_variant Intron 2 of 6 1 NM_002067.5 ENSP00000078429.3 P29992
GNA11ENST00000586763.1 linkn.140-2979T>G intron_variant Intron 1 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.379
AC:
57375
AN:
151190
Hom.:
11795
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.216
Gnomad AMI
AF:
0.285
Gnomad AMR
AF:
0.402
Gnomad ASJ
AF:
0.375
Gnomad EAS
AF:
0.407
Gnomad SAS
AF:
0.399
Gnomad FIN
AF:
0.376
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.471
Gnomad OTH
AF:
0.376
GnomAD2 exomes
AF:
0.417
AC:
102212
AN:
244938
AF XY:
0.420
show subpopulations
Gnomad AFR exome
AF:
0.209
Gnomad AMR exome
AF:
0.410
Gnomad ASJ exome
AF:
0.362
Gnomad EAS exome
AF:
0.406
Gnomad FIN exome
AF:
0.382
Gnomad NFE exome
AF:
0.466
Gnomad OTH exome
AF:
0.421
GnomAD4 exome
AF:
0.457
AC:
657747
AN:
1440758
Hom.:
152629
Cov.:
29
AF XY:
0.455
AC XY:
324903
AN XY:
713850
show subpopulations
African (AFR)
AF:
0.210
AC:
6826
AN:
32562
American (AMR)
AF:
0.405
AC:
17945
AN:
44260
Ashkenazi Jewish (ASJ)
AF:
0.369
AC:
9537
AN:
25878
East Asian (EAS)
AF:
0.438
AC:
17168
AN:
39230
South Asian (SAS)
AF:
0.403
AC:
34313
AN:
85048
European-Finnish (FIN)
AF:
0.385
AC:
20344
AN:
52804
Middle Eastern (MID)
AF:
0.375
AC:
2132
AN:
5682
European-Non Finnish (NFE)
AF:
0.478
AC:
523378
AN:
1095968
Other (OTH)
AF:
0.440
AC:
26104
AN:
59326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
16890
33780
50669
67559
84449
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15488
30976
46464
61952
77440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.379
AC:
57415
AN:
151306
Hom.:
11806
Cov.:
32
AF XY:
0.375
AC XY:
27756
AN XY:
73956
show subpopulations
African (AFR)
AF:
0.217
AC:
8853
AN:
40876
American (AMR)
AF:
0.402
AC:
6133
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.375
AC:
1300
AN:
3470
East Asian (EAS)
AF:
0.408
AC:
2096
AN:
5140
South Asian (SAS)
AF:
0.398
AC:
1903
AN:
4786
European-Finnish (FIN)
AF:
0.376
AC:
3967
AN:
10558
Middle Eastern (MID)
AF:
0.361
AC:
106
AN:
294
European-Non Finnish (NFE)
AF:
0.471
AC:
32002
AN:
67914
Other (OTH)
AF:
0.379
AC:
797
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1799
3598
5396
7195
8994
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.394
Hom.:
4662
Bravo
AF:
0.370

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 29, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.40
DANN
Benign
0.12
PhyloP100
-3.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11085000; hg19: chr19-3110349; COSMIC: COSV50028098; COSMIC: COSV50028098; API